The University of Reading increases stake in Astratus Limited
Published
The University of Reading has increased its stake in Astratus Limited from 2,308 to 305,800 Ordinary shares. The university was already a shareholder at the start of the period. Lamina Dielectrics Limited also increased its holding during this window, growing from 770 to 77,000 Ordinary shares.
These adjustments to the share capital, recorded in a confirmation statement filed on 20 July 2026, may signal a recent funding round. Astratus Limited is a Reading-based medical technology company founded in 2024. It develops a high-throughput antimicrobial susceptibility testing platform that utilizes a microcapillary dip-and-test cassette and instrument reader to provide digital results from urine samples in under six hours.
The technology targets human, veterinary, and research laboratories to modernize microbiology testing and support antimicrobial stewardship. No other new shareholders or exits were recorded in the filing for the period ending 23 June 2026. Astratus Limited continues to develop its diagnostic tools for the healthcare and research sectors from its base in Reading.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| Increased | THE UNIVERSITY OF READING | 305,800 | +13150% | ORDINARY 305,800 |
| Increased | LAMINA DIELECTRICS LIMITED | 77,000 | +9900% | ORDINARY 77,000 |
Current shareholders (3)
| Shareholder | Total shares | Share classes |
|---|---|---|
| THE UNIVERSITY OF READING | 305,800 | ORDINARY 305,800 |
| JFP NOMINEES LIMITED | 80,173 | ORDINARY 80,173 |
| LAMINA DIELECTRICS LIMITED | 77,000 | ORDINARY 77,000 |
Contact the editorial team at [email protected]